Premier Hb9210 Glycated hemoglobin assay - Taiwan Registration 30d217fdd689b9e07d2661b9eddb380f
Access comprehensive regulatory information for Premier Hb9210 Glycated hemoglobin assay in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 30d217fdd689b9e07d2661b9eddb380f and manufactured by Trinity Biotech (Primus Corporation dba Trinity Biotech). The authorized representative in Taiwan is PROGRESSIVE GROUP INC..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
30d217fdd689b9e07d2661b9eddb380f
Ministry of Health Medical Device Import No. 027200
DHA05602720008
Product Details
For details, it is Chinese approved copy of the imitation order. Performance (discretionary) changes: as detailed in Chinese label, instruction manual or package approved version.
B Hematology and pathology devices
B7470 Glycosylated heme analysis
Imported from abroad
Dates and Status
Apr 09, 2015
Apr 09, 2025